Morphokinetic Parameter Monitoring for IVF Embryo Quality Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current quality control methods in IVF clinics are slow to respond and lack sensitivity due to limited sample sizes and delays in obtaining results from HCG tests and scans, making it difficult to accurately monitor embryo developmental conditions and detect changes in embryo handling or environmental issues.

Innovation Solution

The use of morphokinetic parameters, such as cleavage times and cell cycle durations, as continuous variables to monitor embryo development, allowing for faster and more sensitive detection of issues in embryo quality and handling practices.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If traditional quality control methods using HCG tests and scans are used to monitor embryo development, then implantation outcomes can be assessed, but the response time is slow and sensitivity is limited due to discrete binomial outcomes and small sample sizes

Engineering Contradiction:
Improvequality control sensitivityVSAvoidresponse delay
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent transforms the discrete binomial outcome parameters (pregnant/not pregnant) into continuous morphokinetic parameters (cleavage times, cell cycle durations, synchrony metrics). This parameter transformation enables more sensitive detection of quality changes and provides continuous monitoring data rather than delayed binary results, directly resolving the contradiction between measurement precision and response time.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The system performs preliminary quality assessment by monitoring morphokinetic parameters during the incubation period itself, rather than waiting for implantation outcomes. This allows quality control issues to be detected and addressed during the embryo development process, eliminating the inherent delay in traditional post-implantation assessment methods.

Inventive Principle:
Principle #10Preliminary action

2Measurement precision

If a large population of embryos is monitored to achieve statistical significance in quality control, then sensitivity improves, but the time lag increases due to the need to accumulate sufficient data

Engineering Contradiction:
Improvequality control sensitivityVSAvoidmonitoring delay
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

By changing from discrete outcome parameters to continuous morphokinetic parameters, the system achieves higher measurement precision with smaller sample sizes. The continuous nature of morphokinetic data provides more information per embryo, reducing the need for large populations to achieve statistical significance and thereby reducing monitoring delays.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The system implements continuous monitoring of embryo development through time-lapse imaging and automated analysis of morphokinetic parameters. This continuous data collection provides a steady stream of quality information without requiring periodic accumulation of discrete outcomes, enabling timely detection of quality changes with smaller embryo populations.

Inventive Principle:
Principle #20Continuity of useful action

3Productivity

If morphokinetic parameters are used as continuous variables for monitoring, then detection speed and sensitivity improve, but the complexity of data analysis increases

Engineering Contradiction:
Improvequality control response speedVSAvoiddata processing complexity
Core Design Contradiction:
ProductivityVSDevice complexity

Solution Approach 1:

The system employs automated image analysis algorithms that self-calibrate and automatically extract morphokinetic parameters from time-lapse images without requiring manual intervention. The software autonomously identifies cleavage events, measures cell cycle durations, and calculates synchrony metrics, transforming complex image data into meaningful quality indicators automatically, thus resolving the contradiction between productivity and complexity.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent replaces manual quality control assessment with an automated computational system that processes morphokinetic data. The mechanical/manual analysis of embryo development is substituted with computer-based image processing and statistical analysis, enabling rapid processing of continuous parameters while reducing human workload and subjectivity.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

4Reliability

If continuous monitoring of embryo development is implemented, then early detection of handling errors and environmental issues is possible, but the system complexity and cost increase

Engineering Contradiction:
Improveembryo quality assuranceVSAvoidmonitoring system complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The time-lapse incubator system performs multiple functions: it maintains optimal embryo culture conditions, captures time-lapse images, automatically analyzes morphokinetic parameters, and provides quality control monitoring. By combining these functions into a single integrated platform, the system achieves high reliability for embryo quality assurance without proportionally increasing overall system complexity.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The automated image analysis software performs self-calibration and automatically extracts morphokinetic parameters without requiring external intervention or complex manual setup. This self-service capability reduces the operational complexity of continuous monitoring while maintaining high reliability in quality assessment.

Inventive Principle:
Principle #25Self-service

Data Source

PatentEP2890781B1Automatic surveillance of in vitro incubating embryos
Publication Date: 2020.09.23 UNISENSE FERTILITECH AS
  • EP2890781B1 patent drawingFigure 1
  • EP2890781B1 patent drawingFigure 2
  • EP2890781B1 patent drawingFigure 3

AI summary

A computer implemented method for automatically detecting variations and/or abnormalities in the developmental conditions of in vitro incubating embryos, the method comprising the steps of: a) obtaining a first dataset comprising morphokinetic parameters relating to the development of a first group of embryos, b) obtaining a second dataset comprising morphokinetic parameters relating to the development of a second group of embryos, c) modifying the first and second datasets by extracting morphokinetic parameter outliers from the first dataset and or the second datasets, d) calculating the difference between specific morphokinetic parameters from the modified first dataset and the corresponding morphokinetic parameters from the modified second dataset, and monitoring said morphokinetic difference thereby detecting variations in the developmental conditions of the first and second group of embryos.